tiprankstipranks
Trending News
More News >
Third Harmonic Bio, Inc. (THRD)
NASDAQ:THRD
US Market

Third Harmonic Bio, Inc. (THRD) Stock Forecast & Price Target

Compare
31 Followers
See the Price Targets and Ratings of:

THRD Analyst Ratings

Hold
2Ratings
Hold
0 Buy
2 Hold
0 Sell
Based on 2 analysts giving stock ratings to
Third
Harmonic Bio, Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

THRD Stock 12 Month Forecast

Average Price Target

$5.23
▼(-0.38%Downside)
Based on 2 Wall Street analysts offering 12 month price targets for Third Harmonic Bio, Inc. in the last 3 months. The average price target is $5.23 with a high forecast of $5.23 and a low forecast of $5.23. The average price target represents a -0.38% change from the last price of $5.25.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","15":"$15","5.25":"$5.25","8.5":"$8.5","11.75":"$11.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5.23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$5.23</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$5.23</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$5.23</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,5.25,8.5,11.75,15],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2024","6":"Aug<br/>2024","9":"Jan<br/>2025","12":"Apr<br/>2025","25":"Apr<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.36,3.503846153846154,3.647692307692308,3.7915384615384617,3.9353846153846153,4.07923076923077,4.223076923076923,4.366923076923078,4.510769230769231,4.654615384615385,4.798461538461539,4.9423076923076925,5.086153846153847,{"y":5.23,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.36,3.503846153846154,3.647692307692308,3.7915384615384617,3.9353846153846153,4.07923076923077,4.223076923076923,4.366923076923078,4.510769230769231,4.654615384615385,4.798461538461539,4.9423076923076925,5.086153846153847,{"y":5.23,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.36,3.503846153846154,3.647692307692308,3.7915384615384617,3.9353846153846153,4.07923076923077,4.223076923076923,4.366923076923078,4.510769230769231,4.654615384615385,4.798461538461539,4.9423076923076925,5.086153846153847,{"y":5.23,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":10.92,"date":1690848000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.92,"date":1698796800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.73,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.3,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.38,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.31,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.74,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.33,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.42,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.29,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.26,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.45,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.36,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$5.23Average Price Target$5.23Lowest Price Target$5.23
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Raymond James Analyst forecast on THRD
Laura PrendergastRaymond James
Raymond James
Hold
Reiterated
04/14/25
Raymond James reiterates Market Perform Rating on Third Harmonic Bio (THRD)
Morgan Stanley Analyst forecast on THRD
Michael UlzMorgan Stanley
Morgan Stanley
$5$5.23
Hold
-0.38%
Downside
Reiterated
04/14/25
Third Harmonic Bio, Inc. Liquidation and Shareholder Distribution: Analyst Maintains Hold Rating Amid Strategic Uncertainties
LifeSci Capital Analyst forecast on THRD
Sam SlutskyLifeSci Capital
LifeSci Capital
$5.5
Buy
4.76%
Upside
Reiterated
02/11/25
Optimistic Buy Rating for Third Harmonic Bio Amid Promising Trial Results and Safety Concerns
Jefferies Analyst forecast on THRD
Akash TewariJefferies
Jefferies
$7
Hold
33.33%
Upside
Reiterated
01/14/25
Cautious Hold Rating for Third Harmonic Bio Amid Competitive Pressure from Blueprint Medicines
TD Cowen Analyst forecast on THRD
Joseph ThomeTD Cowen
TD Cowen
Buy
Reiterated
11/07/24
TD Cowen Remains a Buy on Third Harmonic Bio, Inc. (THRD)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Raymond James Analyst forecast on THRD
Laura PrendergastRaymond James
Raymond James
Hold
Reiterated
04/14/25
Raymond James reiterates Market Perform Rating on Third Harmonic Bio (THRD)
Morgan Stanley Analyst forecast on THRD
Michael UlzMorgan Stanley
Morgan Stanley
$5$5.23
Hold
-0.38%
Downside
Reiterated
04/14/25
Third Harmonic Bio, Inc. Liquidation and Shareholder Distribution: Analyst Maintains Hold Rating Amid Strategic Uncertainties
LifeSci Capital Analyst forecast on THRD
Sam SlutskyLifeSci Capital
LifeSci Capital
$5.5
Buy
4.76%
Upside
Reiterated
02/11/25
Optimistic Buy Rating for Third Harmonic Bio Amid Promising Trial Results and Safety Concerns
Jefferies Analyst forecast on THRD
Akash TewariJefferies
Jefferies
$7
Hold
33.33%
Upside
Reiterated
01/14/25
Cautious Hold Rating for Third Harmonic Bio Amid Competitive Pressure from Blueprint Medicines
TD Cowen Analyst forecast on THRD
Joseph ThomeTD Cowen
TD Cowen
Buy
Reiterated
11/07/24
TD Cowen Remains a Buy on Third Harmonic Bio, Inc. (THRD)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Third Harmonic Bio, Inc.

1 Month
xxx
Success Rate
7/9 ratings generated profit
78%
Average Return
+12.16%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 77.78% of your transactions generating a profit, with an average return of +12.16% per trade.
3 Months
xxx
Success Rate
5/9 ratings generated profit
56%
Average Return
+3.31%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of +3.31% per trade.
1 Year
Sam SlutskyLifeSci Capital
Success Rate
4/9 ratings generated profit
44%
Average Return
+10.49%
reiterated a buy rating 4 months ago
Copying Sam Slutsky's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of +10.49% per trade.
2 Years
xxx
Success Rate
1/9 ratings generated profit
11%
Average Return
-32.19%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 11.11% of your transactions generating a profit, with an average return of -32.19% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

THRD Analyst Recommendation Trends

Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
3
3
3
2
1
Buy
4
2
0
0
0
Hold
0
1
3
5
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
6
6
7
8
In the current month, THRD has received 1 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. THRD average Analyst price target in the past 3 months is 5.23.
Each month's total comprises the sum of three months' worth of ratings.

THRD Financial Forecast

THRD Earnings Forecast

Next quarter’s earnings estimate for THRD is -$0.23 with a range of -$0.24 to -$0.22. The previous quarter’s EPS was -$0.35. THRD beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.00% of the time in the same period. In the last calendar year THRD has Outperformed its overall industry.
Next quarter’s earnings estimate for THRD is -$0.23 with a range of -$0.24 to -$0.22. The previous quarter’s EPS was -$0.35. THRD beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.00% of the time in the same period. In the last calendar year THRD has Outperformed its overall industry.
No data currently available

THRD Sales Forecast

The previous quarter’s earnings for THRD were $0.00.
The previous quarter’s earnings for THRD were $0.00.

THRD Stock Forecast FAQ

What is THRD’s average 12-month price target, according to analysts?
Based on analyst ratings, Third Harmonic Bio, Inc.’s 12-month average price target is 5.23.
    What is THRD’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for THRD, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is THRD a Buy, Sell or Hold?
        Third Harmonic Bio, Inc. has a consensus rating of Hold which is based on 0 buy ratings, 2 hold ratings and 0 sell ratings.
          What is Third Harmonic Bio, Inc.’s price target?
          The average price target for Third Harmonic Bio, Inc. is 5.23. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $5.23 ,the lowest forecast is $5.23. The average price target represents -0.38% Decrease from the current price of $5.25.
            What do analysts say about Third Harmonic Bio, Inc.?
            Third Harmonic Bio, Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 2 Wall Streets Analysts.
              How can I buy shares of THRD?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis